Advances in intravenous lipid emulsions

Area of Science:

• Biochemistry
• Nutrition Science
• Pharmacology

Background:

• Intravenous lipid emulsions (ILEs) are crucial for nutritional support.
• Traditional soybean oil-based ILEs raise concerns due to high n-6 polyunsaturated fatty acids, potentially impairing immune function and antioxidant status.
• Evolving research highlights the metabolic impact and therapeutic potential of modified ILE compositions.

Purpose of the Study:

• To review the evolving understanding of ILE metabolism and composition.
• To discuss the implications of different fatty acid profiles (n-6 vs. n-3) in ILEs.
• To explore the potential of modified ILEs in managing acute and chronic diseases.

Main Methods:

• Literature review and synthesis of current research on ILE metabolism.
• Analysis of the metabolic pathways and tissue-specific delivery of ILE components.
• Evaluation of the impact of different triglyceride compositions on physiological responses.

Main Results:

• ILE metabolism pathways and component delivery are better understood.
• Soybean oil-based ILEs' high n-6 fatty acid content may negatively affect immunity and antioxidant status.
• Medium-chain triglycerides, olive oil, and n-3 fatty acids offer potential advantages by mitigating disadvantages and reducing inflammation.

Conclusions:

• ILEs are more than energy substrates; they actively modulate key metabolic functions.
• Modified ILE compositions, particularly those incorporating n-3 fatty acids, show promise for therapeutic applications in various diseases.
• Optimized metabolic care for patients can be achieved through a deeper understanding of ILE metabolism and tailored formulations.